Tesalin® – Ze 339

Tesalin® – Ze 339

Tesalin® – Ze 339

This is an authorised medicinal product.

Product information

For the treatment of intermittent (seasonal) allergic rhinitis and related symptoms of the eyes, nose and throat

17.8 - 40 mg CO2 extract (Ze 339) from the leaves of Petasites hybridus, standardized to 8 mg petasins

Drug-extract ratio (DER): 50-100:1

Patented sub-critical CO2 extraction

2-3 x 1 film-coated tablets per day.

Butterbur (Petasites hybridus)
Dictionary of medicinal plants


Petasites hybridus – helps to relieve allergies such as hay fever.


Clinical Evidence & Mode of action

The information contained in this section is intended for healthcare professionals only.

Please click the button below to confirm that you are a healthcare professional.


Get in Touch

Max Zeller Soehne AG Seeblickstr. 4 8590 Romanshorn Switzerland

P: +41 71 466 05 00 bd@zellerag.ch


Ze 339 – The Difference

New Herbal Entity – Ze 339 is the first Petasites hybridus leaf extract for the treatment of allergic rhinitis, with no similar product worldwide

Dual action – Alleviates broad range of allergic rhinitis complaints including allergic (rhinorrhea, itching etc.) and inflammatory symptoms (nasal congestion) by inhibiting synthesis of leukotrienes and release of various inflammatory mediators

Highly effective - Proven equal efficacy in head-to-head trials with antihistamines

Excellent safety & tolerability – Low incidence of adverse effects and no sedative effect

Moderne-Pflanzenheilkunde-Phytotherapie.jpg Moderne-Pflanzenheilkunde-Phytotherapie.jpg


Our phyto-pharmaceuticals have proven efficacy, tolerability and safety in numerous clinical trials performed by Zeller and published in peer-reviewed journals.


Further products